• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Comprehensive Overview of N-Dodecyldeoxynojirimycin (CAS No. 79206-22-7): Mechanism, Applications, and Research Insights

N-Dodecyldeoxynojirimycin (CAS No. 79206-22-7), often abbreviated as ND-DNJ, is a synthetic derivative of deoxynojirimycin (DNJ), a naturally occurring iminosugar. This compound has garnered significant attention in biochemical and pharmaceutical research due to its unique glycosidase inhibition properties. The addition of a dodecyl chain enhances its lipophilicity, enabling improved cellular membrane penetration and bioavailability. Researchers are particularly interested in its potential to modulate glycoprotein processing, a critical pathway in metabolic and infectious diseases.

In recent years, the scientific community has explored N-Dodecyldeoxynojirimycin as a candidate for addressing viral infections and lysosomal storage disorders. Its ability to inhibit alpha-glucosidases makes it a promising tool for studying endoplasmic reticulum (ER) stress and autophagy—topics frequently searched in connection with neurodegenerative diseases like Alzheimer's and Parkinson's. Moreover, its role in glycosphingolipid metabolism has linked it to Gaucher disease research, a trending topic in rare disease therapeutics.

The compound’s mechanism of action involves competitively binding to glycosidase enzymes, disrupting the cleavage of glucose residues from glycoproteins and glycolipids. This property is leveraged in antiviral studies, where ND-DNJ has shown efficacy against enveloped viruses like HIV and hepatitis B by interfering with viral glycoprotein maturation. Such applications align with current public health interests, as evidenced by frequent searches for "broad-spectrum antiviral agents" and "host-targeted antivirals."

From a structural perspective, the dodecyl tail of N-Dodecyldeoxynojirimycin distinguishes it from shorter-chain analogs like N-butyldeoxynojirimycin (NB-DNJ). This modification not only enhances pharmacokinetics but also broadens its utility in lipid raft studies, a hot topic in cancer and immunology research. The compound’s amphiphilic nature allows it to integrate into cell membranes, making it valuable for probing membrane-associated signaling pathways.

Ongoing clinical and preclinical studies highlight ND-DNJ’s potential in personalized medicine, particularly for metabolic syndromes. Its dual action on glycolipid biosynthesis and protein folding pathways resonates with current searches for "multi-target therapeutics." Additionally, its low toxicity profile in vitro positions it as a safer alternative to harsher enzyme inhibitors, addressing the growing demand for biocompatible research chemicals.

In summary, N-Dodecyldeoxynojirimycin (CAS No. 79206-22-7) represents a versatile tool in modern biochemistry, bridging gaps between glycobiology, virology, and rare disease research. Its relevance to trending topics like ER stress, viral pathogenesis, and lipid metabolism ensures continued interest from both academic and pharmaceutical sectors. As studies progress, this compound may unlock novel therapeutic strategies aligned with today’s emphasis on mechanism-driven drug discovery.

• 70956-02-4(1-Deoxynojirimycin)
• 119557-99-2(α-Homonojirimycin)
• 76144-81-5(Mildronate)
• 72432-03-2(Miglitol)
• 19130-96-2(1-Deoxynojirimycin)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)